Enanta Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-6.564; its P/E ratio is -2.00; Enanta Pharmaceuticals is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-1.34. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 18.00M	$ 18.89M	$ 17.80M	$ 23.59M	$ 20.32M
Gross Profit	$ 18.00M	$ 18.89M	$ 17.80M	$ 23.59M	-
EBIT	$ -30.59M	$ -32.85M	$ -37.61M	$ -30.01M	$ -27.05M
EBITDA	$ -29.67M	$ -33.64M	$ -38.08M	$ -29.84M	$ -26.39M
Net Income Common Stockholders	$ -33.41M	$ -39.06M	$ -37.66M	$ -28.99M	$ -26.35M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 337.15M	$ 386.58M	$ 210.08M	$ 214.47M	$ 249.23M
Total Assets	$ 428.50M	$ 495.17M	$ 326.44M	$ 347.53M	$ 375.41M
Total Debt	$ 25.49M	$ 27.70M	$ 28.00M	$ 25.34M	$ 25.26M
Net Debt	$ -311.66M	$ -358.88M	$ -182.09M	$ -189.13M	$ -223.97M
Total Liabilities	$ 236.62M	$ 257.35M	$ 57.07M	$ 46.70M	$ 54.08M
Stockholders Equity	$ 191.88M	$ 237.82M	$ 269.38M	$ 300.84M	$ 321.33M
Cash Flow	-
Free Cash Flow	$ -25.77M	$ -34.28M	$ -16.17M	$ -38.80M	$ -16.97M
Operating Cash Flow	$ -24.99M	$ -32.13M	$ -13.78M	$ -35.64M	$ -15.53M
Investing Cash Flow	$ -13.12M	$ -145.75M	$ 46.77M	$ 33.57M	$ 28.23M
Financing Cash Flow	$ -7.35M	$ 199.88M	$ -2.03M	$ 301.00K	$ 2.93M

Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History

Income Statement >

Enanta Pharmaceuticals Debt to Assets

Balance Sheet >

Enanta Pharmaceuticals Cash Flow

Cash Flow >

Enanta Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing